Table of contents
- Key Takeaways:
- What Is Ind AS 102 and Which Share Based Payment Transactions Does It Cover?
- Grant Date, Vesting Date and the Vesting Conditions That Drive ESOP Accounting
- How Is Fair Value Measured Under Ind AS 102? Black Scholes vs Binomial Models
- Recognising ESOP Expense: Straight Line vs Graded Vesting Method
- Accounting for ESOP Modifications, Cancellations and Forfeitures
- Equity Settled vs Cash Settled Share Based Payments: Key Accounting Differences
- Deferred Tax on ESOP Expense Under Ind AS 12
- Disclosure Requirements Under Ind AS 102 Financial Statements
- How to Build an Audit-Ready Ind AS 102 ESOP Expense Model in 5 Steps
- Ind AS 102 Fair Value vs Income Tax Perquisite Valuation: Reconciling the Two Numbers
- SEBI SBEB and Sweat Equity Regulations 2021: Interplay With ESOP Accounting
- 7 Common Mistakes in Ind AS 102 ESOP Accounting
- Closing Summary: Ind AS 102 Rewards Discipline, Not Shortcuts
- Frequently Asked Questions — Ind AS 102 ESOP Accounting
📌 For CFOs, Auditors & Finance Controllers — What You Must Know
Ind AS 102 mandates the fair value method, not intrinsic value, for every equity settled ESOP scheme, and that fair value is locked in on the grant date regardless of how the share price moves afterward.
- Grants that vest in tranches must be split into separate awards under the graded vesting method, front loading expense into the earlier years
- Deferred tax on ESOP expense is computed under Ind AS 12, paragraphs 68A to 68C, using intrinsic value at each reporting date, not the fair value used for the accounting charge
- Cancellations trigger immediate recognition of the remaining expense, while modifications that increase fair value add an incremental charge on top of the original grant date cost
- A December 2025 amendment to the SEBI SBEB and Sweat Equity Regulations, 2021 shifted certain ESOP related valuations from merchant bankers to IBBI registered valuers, effective 2 January 2026
Every finance controller who has sat through a statutory audit knows the moment: the auditor asks how the ESOP expense for the quarter was computed, and the answer that follows determines whether the closing runs smoothly or turns into a three week reconciliation exercise. Ind AS 102 is deceptively short as a standard, but it is one of the most frequently misapplied areas of Indian financial reporting, because the correct accounting depends on getting several interlocking judgments right at once: the fair value model, the vesting condition classification, the tranche by tranche amortisation schedule, and the deferred tax treatment that runs on an entirely different measurement base from the accounting expense itself.
The stakes are not academic. A company that expenses its ESOP pool incorrectly typically discovers the error at the worst possible time, during a fundraising due diligence process or a listing readiness review, when a restatement of two or three years of financial statements becomes unavoidable. Getting the fair value input right also matters commercially, since it feeds directly into the Rule 11UA fair market value conversation and the exercise price debate with the ESOP committee.
At Elite Valuation, we support Indian companies with grant date fair value reports, Ind AS 102 expense schedules, and the coordination between accounting fair value and the statutory valuation required under the Companies Act for ESOP allotments. This guide walks through exactly how Ind AS 102 works in practice, from grant date to exercise, so that finance teams can build a defensible, audit ready ESOP accounting process
Key Takeaways:
- Ind AS 102 mandates fair value, measured at grant date, for equity settled ESOPs, ESPPs and similar instruments, replacing the older intrinsic value practice entirely
- Graded vestingrequires each vesting tranche to be treated as a separate grant with its own fair value and its own service period, not averaged across the whole pool
- Expense already recognised must be reversed on forfeiture for service or non-market performance conditions, but never reversed for a failed market condition once service is rendered
- Cancellations by the company accelerate the remaining unrecognised expense into the period of cancellation; modifications that raise fair value add an incremental charge over the remaining vesting period
- Cash settled awards such as stock appreciation rights are remeasured to fair value at every reporting date as a liability, unlike equity settled awards which are fixed at grant
- Deferred tax under Ind AS 12 uses intrinsic value at each reporting date, capped at the cumulative accounting expense, with any excess taken directly to equity
- Non-Ind AS companies now largely follow the same fair value approach under the ICAI Guidance Note (2020), applicable to grants from 1 April 2021 onward
- The SEBI SBEB Regulations, 2021 govern scheme design and pricing for listed companies but do not replace Ind AS 102 for accounting purposes
- A December 2025 SEBI amendment requires IBBI registered valuers, not merchant bankers, for new sweat equity valuations from 2 January 2026 onward
What Is Ind AS 102 and Which Share Based Payment Transactions Does It Cover?
Scope and Applicability
Ind AS 102, Share Based Payment, is the accounting standard that governs how an entity recognises the cost of goods or services received in exchange for its own equity instruments, cash amounts based on the value of its equity instruments, or a choice between the two. In practice, for most Indian companies this standard is about one thing: how to expense the cost of employee stock options, employee stock purchase plans, and stock appreciation rights in the profit and loss account, rather than treating them as a cost free form of compensation.
The standard applies mandatorily to companies covered under the Companies (Indian Accounting Standards) Rules, 2015, which phased in Ind AS from 1 April 2016 based on net worth and listing status, eventually covering all listed companies and unlisted companies above prescribed net worth thresholds. Companies outside this framework, typically smaller private companies, instead follow Indian GAAP under the Companies (Accounting Standards) Rules, 2006, supplemented by the ICAI Guidance Note on Accounting for Share based Payments (2020), which is discussed later in this guide.
📌 The Three Categories of Share Based Payment Under Ind AS 102
- Equity settled transactions — the entity receives services in exchange for equity instruments such as stock options or restricted shares, and settles by issuing shares
- Cash settled transactions — the entity incurs a liability based on the value of its equity instruments, such as stock appreciation rights (SARs) settled in cash
- Transactions with a choice of settlement — either the entity or the counterparty can choose whether the award is settled in cash or in equity, requiring a split accounting treatment
The scope extends beyond employees to any party providing goods or services, including consultants, advisors and, under specific provisions, transactions arising within a business combination. However, the overwhelming majority of Ind AS 102 questions that Indian finance teams face relate to employee stock option schemes, so this guide focuses primarily on that context while addressing SARs and cash settled awards where the accounting genuinely diverges.
Grant Date, Vesting Date and the Vesting Conditions That Drive ESOP Accounting
Before any expense can be computed, four dates and three types of vesting condition need to be correctly identified, because each one changes the accounting outcome in a different way.
| Date | What It Represents | Why It Matters |
|---|---|---|
| Grant Date | The date the entity and employee agree on the terms of the award, and both parties have a shared understanding of the terms and conditions. | Fair value is measured on this date and, for equity-settled awards, is never remeasured afterward. |
| Service Commencement Date | The date from which the employee begins rendering service toward the award, sometimes earlier than the grant date. | Expense may need to begin accruing before the grant date if service starts earlier. |
| Vesting Date | The date on which the employee becomes unconditionally entitled to the award. | Marks the end of the period over which the grant date fair value is expensed. |
| Exercise Date | The date the employee actually exercises the vested option and receives shares. | Relevant for cash flow, share capital accounting and the income tax perquisite computation, not for the Ind AS 102 expense itself. |
The nature of the vesting condition attached to an award is equally important, because Ind AS 102 treats each category differently when it comes to reversing expense on failure.
Service Conditions
Time Based
True-Up Required
A vesting condition requiring the employee to complete a specified period of continuous employment, with no performance target attached. If the employee leaves before the service period ends, the option lapses and any cumulative expense recognised for that employee must be reversed.
Non-Market Performance Conditions
Revenue, EBITDA, Profit Targets
True-Up Required
A vesting condition tied to internal performance metrics unrelated to the entity's share price, such as achieving a specified EBITDA margin or revenue growth target. These conditions are not built into the grant date fair value; instead, the entity re-estimates at each reporting date whether the condition is expected to be met and adjusts the expense accordingly, with a full reversal if the target is ultimately missed.
Market Conditions
Share Price Targets, TSR Hurdles
No Reversal, Ever
A vesting condition related to the market price of the entity's own equity instruments, such as a target share price or a relative total shareholder return hurdle. Market conditions are built directly into the option pricing model at grant date using simulation techniques, and critically, the resulting expense is never reversed for failure to achieve the market condition as long as the employee satisfies the service requirement.
Non-Vesting Conditions
Contribution or Savings Plans (ESPP)
No Reversal
Conditions that neither the entity nor the counterparty can control being met, such as an ongoing employee contribution requirement under a savings linked ESPP. Like market conditions, these are factored into the grant date fair value and are not trued up if the condition changes, though failure caused by either party within their control is treated as a cancellation.
How Is Fair Value Measured Under Ind AS 102? Black Scholes vs Binomial Models
Measurement Phase
Ind AS 102, paragraphs 11 and 12, require equity settled share based payments to employees to be measured at the fair value of the equity instruments granted, because the fair value of the services received is rarely observable directly. This fair value must reflect, at minimum, the exercise price, the expected life of the option, the current price of the underlying shares, the expected volatility, the expected dividends, and the risk free interest rate over the life of the option.
| Input | What It Represents | Typical Source for Unlisted Companies |
|---|---|---|
| Underlying Share Price | Current fair value of one equity share on the valuation date. | A Rule 11UA or independent DCF based valuation, since no quoted price exists. |
| Exercise Price | Price the employee pays to exercise the option. | Fixed in the ESOP scheme document at grant. |
| Expected Volatility | Annualised standard deviation of returns on the underlying share. | Derived from a comparable listed peer set, since historical volatility for the company itself is unavailable. |
| Expected Life | Expected time until exercise, generally shorter than the full contractual term. | Based on vesting schedule, exercise window and historical exercise behaviour where available. |
| Risk Free Rate | Government security yield matching the expected life of the option. | Government of India securities yield curve. |
| Expected Dividends | Anticipated dividend yield over the expected life. | Based on stated dividend policy or historical payout pattern. |
📌 Black Scholes vs Binomial Lattice Models
The Black Scholes model is a closed form solution best suited to plain vanilla options with a single exercise date and no unusual features, and remains the most widely used model for standard ESOPs in India. A binomial or lattice model is required, or strongly preferred, when the award has variable exercise behaviour over an exercise window, contains market conditions such as a share price hurdle, or has other features that a simple closed form model cannot capture. For SARs and awards with performance linked vesting tied to share price, a lattice or Monte Carlo simulation approach is typically the only defensible choice.
A point of frequent error for unlisted companies concerns the volatility input. The ICAI's 2020 revision to its Guidance Note explicitly removed the earlier practice of assuming zero historical volatility for unlisted entities, since a genuinely private company still carries equity price risk that a proxy volatility from comparable listed peers is expected to reflect. Using zero or artificially low volatility understates the option's time value and produces a fair value that auditors are increasingly unwilling to accept, whether the company reports under Ind AS or under the Guidance Note framework.
Need a Defensible Grant Date Fair Value for Your ESOP Scheme?
We prepare Ind AS 102 compliant fair value reports using Black Scholes and binomial models, benchmarked volatility for unlisted companies, and full audit documentation your statutory auditor can rely on.
Recognising ESOP Expense: Straight Line vs Graded Vesting Method
Expense Recognition Phase
Once the fair value is determined, the next judgment is how to spread that cost across the vesting period. Many finance teams default to a simple straight line allocation of the total pool cost across the longest vesting tranche, but this is not what Ind AS 102 actually requires whenever a grant vests in more than one tranche on more than one date.
Paragraph 10 of Ind AS 102, read with the standard's illustrative guidance, requires that where a single grant has multiple vesting dates, it must be treated as if it were several separate grants, each with its own fair value calculated using the expected life appropriate to that specific tranche, and each expensed on a straight line basis over its own vesting period. This is known as the graded vesting method, and it produces a materially different, and generally front loaded, expense pattern compared to averaging the total cost evenly across the full vesting term.
📌 Illustrative Computation — Graded Vesting for a Four Year ESOP Grant
Consider 40,000 options granted to an employee, vesting 25 percent each year over four years, with a total pool level fair value that differs slightly by tranche because each tranche has a different expected life input. Under the graded vesting method, each 10,000 option tranche is treated as its own grant:
| Input | What It Represents | Typical Source for Unlisted Companies |
|---|---|---|
| Underlying Share Price | Current fair value of one equity share on the valuation date. | A Rule 11UA or independent DCF based valuation, since no quoted price exists. |
| Exercise Price | Price the employee pays to exercise the option. | Fixed in the ESOP scheme document at grant. |
| Expected Volatility | Annualised standard deviation of returns on the underlying share. | Derived from a comparable listed peer set, since historical volatility for the company itself is unavailable. |
| Expected Life | Expected time until exercise, generally shorter than the full contractual term. | Based on vesting schedule, exercise window and historical exercise behaviour where available. |
| Risk Free Rate | Government security yield matching the expected life of the option. | Government of India securities yield curve. |
| Expected Dividends | Anticipated dividend yield over the expected life. | Based on stated dividend policy or historical payout pattern. |
Because Tranche 1 is fully expensed within a single year while Tranche 4 is spread across four years, the annual profit and loss charge in Year 1 includes the full Tranche 1 cost plus a proportionate share of Tranches 2, 3 and 4, resulting in a Year 1 charge that is considerably higher than one quarter of the total pool cost. This front loading effect surprises many finance teams the first time a multi-year ESOP scheme is expensed correctly, and it is one of the most common sources of prior period errors that surface during an audit.
⚠️ Common Restatement Trigger. Companies that amortise the entire pool cost on a simple straight line basis over the longest tranche, rather than applying the graded vesting method tranche by tranche, systematically understate expense in the earlier years and overstate it later. When this is identified during a statutory audit, a listing process or an investor due diligence review, it typically requires a restatement of prior period financial statements, since the error affects the timing, not just the presentation, of the expense.
Accounting for ESOP Modifications, Cancellations and Forfeitures
Forfeiture — Service or Non-Market Performance Condition Fails
When an employee resigns before completing the service period, or a non-market performance target is ultimately missed, the cumulative expense recognised for that specific award to date must be reversed through the profit and loss account. This is treated as if the service was never rendered, since the entity never actually received the benefit it was accounting for.
Failure of a Market Condition
If the employee completes the required service period but a market condition, such as a share price target, is never achieved, the option lapses commercially but the accounting expense already recognised is not reversed. Ind AS 102 treats this as a vesting event for accounting purposes because the market condition was already priced into the grant date fair value.
Cancellation by the Entity
When the company cancels or settles a grant before the end of the vesting period, other than due to employee forfeiture, this is treated as an acceleration of vesting. Any expense that would otherwise have been recognised over the remaining vesting period must instead be recognised immediately in the period of cancellation, rather than spread out or reversed.
Modification That Increases Fair Value (Repricing, Extended Term)
If the entity modifies the terms of a grant in a way that increases its fair value, for example by reducing the exercise price or extending the exercise window, the entity continues to expense the original grant date fair value as before, and separately recognises the incremental fair value, measured as the difference between the modified and original fair value at the modification date, over the remaining vesting period.
Modification That Decreases Fair Value
Where a modification reduces the fair value of the award, for example by increasing the exercise price, Ind AS 102 does not permit a corresponding reduction in the expense already being recognised. The entity continues to recognise the original grant date fair value as if the modification had never occurred, since the standard treats modifications asymmetrically to prevent companies from using unfavourable modifications to reduce reported expense.
Equity Settled vs Cash Settled Share Based Payments: Key Accounting Differences
Stock appreciation rights and other cash settled instruments are increasingly used by Indian companies, particularly where the ESOP pool has been exhausted or where the company wants to avoid equity dilution. The accounting for these instruments diverges from standard ESOPs in a way that has a real impact on reported volatility.
| Feature | Equity Settled (ESOP) | Cash Settled (SAR) |
|---|---|---|
| Measurement Date | Fixed at grant date only. | Remeasured at every reporting date and at final settlement. |
| Balance Sheet Classification | Recognised in equity (share based payment reserve). | Recognised as a liability. |
| Expense Volatility | Predictable, fixed total cost known at grant. | Fluctuates with share price movement each period until settlement. |
| Dilution Impact | Yes, on exercise new or treasury shares are issued. | None, since settlement is entirely in cash. |
| Cumulative Cost on Settlement | Equal to the grant date fair value multiplied by vested units. | Equal to the actual cash paid on settlement, which may be higher or lower than initial estimates. |
Because the liability for a cash settled award is remeasured every period, a rising share price directly increases the reported expense in the period of the increase, which can create meaningful profit and loss volatility for companies with large SAR pools. Some schemes also offer a choice of settlement, either to the employee or to the entity, and these require the more complex split accounting under Ind AS 102's compound instrument provisions, generally warranting specialist input given the judgment involved in separating the liability and equity components.
Structuring a New ESOP, SAR or Hybrid Scheme?
We advise on scheme design, exercise pricing, pool sizing and the accounting implications of equity settled versus cash settled structures before the scheme is finalised, not after the first audit query arrives.
Deferred Tax on ESOP Expense Under Ind AS 12
The deferred tax treatment of ESOP expense is one of the least intuitive areas of Ind AS compliance, because the deferred tax asset is not simply the tax rate applied to the accounting expense. Paragraphs 68A to 68C of Ind AS 12, Income Taxes, set out a distinct measurement basis for the tax effect of share based payments.
✔ How the Ind AS 12 Deferred Tax Computation Actually Works
- The tax base of the ESOP related cost is nil until a tax deductible event occurs, which under Indian income tax law is generally the exercise of the option, not the grant or vesting
- At each reporting date, the entity estimates the deferred tax asset using the intrinsic value of the option at that date, being the difference between the current share price and the exercise price, not the grant date fair value used for the accounting expense
- The deferred tax asset recognised in any period is capped at the cumulative remuneration expense already recognised for that award, multiplied by the applicable tax rate
- If the estimated future tax deduction, based on intrinsic value, exceeds the cumulative accounting expense recognised, the excess deferred tax is recognised directly in equity, not in profit or loss
- The deferred tax asset must be reassessed at every reporting date as the underlying share price and intrinsic value change, introducing genuine volatility into the tax line that is unrelated to the entity's actual taxable profit
This dual measurement basis, fair value for the accounting expense and intrinsic value for the deferred tax, is a frequent source of reconciliation error, particularly for companies whose share price has appreciated significantly since grant date. In a rising share price scenario, the intrinsic value can substantially exceed the grant date fair value, meaning the deferred tax asset computed under Ind AS 12 may exceed what a simple multiplication of the accounting expense by the tax rate would suggest, with the excess routed through equity rather than the income statement.
Disclosure Requirements Under Ind AS 102 Financial Statements
Beyond the recognition and measurement rules, Ind AS 102 imposes detailed disclosure obligations designed to let a reader of the financial statements understand the nature, extent and financial impact of the entity's share based payment arrangements.
✔ Minimum Ind AS 102 Disclosure Checklist
- A description of each type of share based payment arrangement, including general terms and conditions, vesting requirements and the maximum term of options granted
- A reconciliation of the number and weighted average exercise price of options outstanding at the beginning and end of the period, showing options granted, exercised, forfeited and expired separately
- The range of exercise prices and the weighted average remaining contractual life for options outstanding at the end of the reporting period
- The valuation model used (Black Scholes, binomial, Monte Carlo) together with all significant inputs, including share price, exercise price, expected volatility, expected life, expected dividends and the risk free rate
- The total expense recognised in profit or loss for the period arising from share based payment transactions
- For cash settled arrangements, the carrying amount of the liability at the end of the period and the intrinsic value of vested but unexercised rights
- Where graded vesting is applied, a description of the tranche level treatment and the resulting weighted average fair value
Auditors and financial statement users increasingly scrutinise the volatility and expected life inputs specifically, since these two assumptions have the largest influence on fair value for a typical Indian ESOP structure, and disclosure of a sensitivity range around these inputs, while not mandatory, is considered good practice for larger listed companies.
How to Build an Audit-Ready Ind AS 102 ESOP Expense Model in 5 Steps
Most Ind AS 102 errors originate not in the accounting judgment itself but in how the expense model is built at the outset. The following sequence, applied from the grant date rather than reconstructed before an audit, produces a schedule that holds up under review.
1. Finalise Grant Data and Tranche Structure
Capture the exact vesting schedule, exercise price, contractual term and the nature of each vesting condition (service, non-market performance or market) for every grant before any fair value work begins, since these inputs determine the entire downstream model.
2. Select the Valuation Model and Lock the Grant Date Fair Value
Choose Black Scholes for plain vanilla options or a binomial or lattice model where market conditions or variable exercise behaviour exist, and freeze the resulting fair value per tranche as of grant date for equity settled awards, since it will not be remeasured later.
3. Build the Tranche-Level Amortisation Schedule
Apply the graded vesting method by creating a separate straight line amortisation schedule for each tranche, then sum the tranches to arrive at the total periodic expense, rather than allocating the pool cost evenly across the longest vesting date.
4. Track Forfeitures and True Up the Estimate Every Quarter
Build an expected forfeiture rate into the model from day one, and revise the number of awards expected to vest at every reporting date based on actual attrition, reversing expense only where a service or non-market performance condition has genuinely failed.
5. Reconcile Deferred Tax Separately Using Intrinsic Value
Maintain an independent intrinsic value tracker, updated at each reporting date, to compute the Ind AS 12 deferred tax asset, and reconcile it explicitly against the cumulative accounting expense so the cap and the equity-routed excess are both documented for the auditor.
Ind AS 102 Fair Value vs Income Tax Perquisite Valuation: Reconciling the Two Numbers
Cross-Compliance Phase
Finance teams frequently assume that a single valuation number can serve both the accounting and tax purposes of an ESOP scheme. It cannot, and conflating the two is one of the more consequential mistakes in ESOP compliance.
| Feature | Equity Settled (ESOP) | Cash Settled (SAR) |
|---|---|---|
| Measurement Date | Fixed at grant date only. | Remeasured at every reporting date and at final settlement. |
| Balance Sheet Classification | Recognised in equity (share based payment reserve). | Recognised as a liability. |
| Expense Volatility | Predictable, fixed total cost known at grant. | Fluctuates with share price movement each period until settlement. |
| Dilution Impact | Yes, on exercise new or treasury shares are issued. | None, since settlement is entirely in cash. |
| Cumulative Cost on Settlement | Equal to the grant date fair value multiplied by vested units. | Equal to the actual cash paid on settlement, which may be higher or lower than initial estimates. |
Note that both the Ind AS 102 accounting fair value and the Companies Act valuation are anchored to the grant date, while the income tax perquisite computation is anchored to the exercise date, potentially years apart and at a very different share price. This means the accounting expense a company books over the vesting period and the eventual TDS obligation it must withhold on exercise are calculated from two entirely different valuation dates and, in most cases, two different valuation professionals. Our detailed guide on share valuation methods in India covers the Rule 11UA mechanics that typically underpin the exercise date perquisite computation, and our guide on when company valuation is mandatory in India sets out the Companies Act trigger for the grant date valuer report in more detail.
⚠️ A Single Valuation Report Rarely Covers All Three Purposes. Because the valuation date, the standard of value and the required professional differ across Ind AS 102 accounting, Companies Act compliance and income tax perquisite computation, companies that commission one valuation and attempt to stretch it across all three purposes frequently find that at least one use case is not properly supported when reviewed by the statutory auditor or the tax officer.
⚠️ TDS Default Risk on the Perquisite Leg. Since the employer must deduct TDS under Section 192 on the perquisite value at exercise, an understated exercise date fair market value results in short deduction of tax at source. This exposes the company to interest under Section 201(1A) and a penalty under Section 271C that can extend up to the amount of tax not deducted, entirely separate from any consequence arising from the Ind AS 102 accounting treatment itself.
SEBI SBEB and Sweat Equity Regulations 2021: Interplay With ESOP Accounting
Listed Company Compliance Phase
For listed companies, the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 govern scheme design, shareholder approval, trust structures and pricing mechanics across six categories of scheme: employee stock option schemes, employee stock purchase plans, stock appreciation rights, general employee benefit schemes, retirement benefit schemes, and sweat equity. These regulations consolidated the earlier 2014 SBEB Regulations and the 2002 Sweat Equity Regulations into a single framework.
It is important for finance teams to understand that the SEBI regulations and Ind AS 102 operate on entirely separate tracks. SEBI's rules address governance matters, such as whether promoters can participate in a scheme, the cap on secondary market acquisition by an employee welfare trust, and the shareholder approval thresholds for schemes involving more than a specified percentage of paid up capital. None of this changes the Ind AS 102 accounting requirement: a listed company must still expense its ESOP scheme at fair value, using the graded vesting method where applicable, regardless of how the SEBI regulations price or structure the scheme.
📌 A Regulatory Change Finance Teams Should Track
A December 2025 amendment, the SEBI (Share Based Employee Benefits and Sweat Equity) (Second Amendment) Regulations, 2025, revised Regulation 34 so that new sweat equity valuations must be conducted by an IBBI registered valuer rather than a merchant banker, aligning the definition of "valuer" with Section 247 of the Companies Act 2013. The change takes effect thirty days after Gazette publication, with merchant bankers permitted to complete only assignments already in progress within a nine month window, meaning new sweat equity valuations commissioned from 2 January 2026 onward require an IBBI registered valuer. A separate September 2025 amendment inserted Regulation 9A, clarifying that employees who become classified as promoters ahead of an IPO can continue to hold and exercise options or SARs granted at least one year before the draft offer document was filed.
For companies preparing an IPO or already listed, this means the valuer engaged for a sweat equity component of an ESOP linked scheme needs to hold IBBI registration going forward, even though the Ind AS 102 fair value computation for the accounting expense itself can continue to be performed by any suitably qualified valuation professional, since Ind AS 102 does not itself prescribe a specific valuer category the way the SEBI regulation now does for sweat equity.
Preparing ESOP Accounting and SEBI Compliance for a Listing or Funding Round?
We coordinate Ind AS 102 fair value computation, Companies Act grant date valuation, and SEBI SBEB compliant sweat equity valuation as IBBI registered valuers, so your ESOP scheme holds up across every regulatory lens at once.
📁 A Recent Engagement
Mid-Size Technology Company
4-Year Graded Vesting ESOP
Pre-Listing Readiness Review
A technology company preparing for a future listing approached us during a financial readiness review, having expensed its ESOP pool of roughly 4,80,000 options on a simple straight line basis across the full four year vesting term since the scheme's inception three years earlier. Our review found that the scheme in fact vested 25 percent per year, meaning the graded vesting method under Ind AS 102 was the required treatment, not the straight line pool average the company had applied.
Recomputing the expense tranche by tranche, using separate fair values reflecting the shorter expected life of earlier tranches, increased the cumulative expense recognised in the first two years by approximately Rs. 1.9 crore, with a corresponding reduction in the expense that would otherwise have fallen in years three and four. Because the error affected the timing of expense recognition across multiple reporting periods already closed, the company's auditors required a restatement of the prior two years' financial statements before the listing readiness review could proceed. We also identified that the deferred tax asset had been computed using the same fair value figure as the accounting expense, rather than the intrinsic value required under Ind AS 12, resulting in a further correction to the deferred tax balance. Addressing both issues before the formal audit for the listing year avoided a qualified opinion and gave the company a clean, defensible ESOP expense trail heading into its listing documentation.
7 Common Mistakes in Ind AS 102 ESOP Accounting
❌ Using intrinsic value instead of fair value
Some companies, particularly those transitioning from older Indian GAAP practice, continue to measure ESOP cost as the difference between share price and exercise price on the balance sheet date, ignoring the time value of the option entirely.
Fix: Engage a qualified valuer to compute grant date fair value using Black Scholes or a binomial model, fixed permanently at grant date for equity settled awards.
❌ Averaging pool cost on a straight line basis instead of applying graded vesting
Spreading the total fair value of a multi-tranche grant evenly across the longest vesting period, rather than treating each tranche as a separate grant with its own fair value and service period, understates expense in earlier years.
Fix: Build the expense schedule tranche by tranche from the outset, with a distinct fair value and vesting period for each vesting date in the scheme.
❌ Reversing expense for a failed market condition
Treating a missed share price target the same way as a missed service condition, and reversing the cumulative expense, contradicts Ind AS 102's explicit rule that market conditions, once priced into the grant date fair value, do not trigger a reversal on failure.
Fix: Confirm whether the vesting condition is market based before deciding on reversal treatment; only service and non-market performance condition failures permit a reversal.
❌ Not trueing up estimated forfeitures during the vesting period
Ind AS 102 requires an entity to estimate the number of awards expected to vest based on anticipated forfeitures, and revise that estimate at each reporting date, rather than only adjusting when an actual resignation occurs.
Fix: Build a forfeiture rate assumption into the expense model from grant date, and revisit it at every reporting period based on actual attrition experience.
❌ Computing deferred tax on fair value instead of intrinsic value
Applying the tax rate directly to the Ind AS 102 accounting expense, rather than following the distinct intrinsic value based computation under Ind AS 12 paragraphs 68A to 68C, produces an incorrect deferred tax asset, particularly where the share price has moved significantly since grant.
Fix: Maintain a separate intrinsic value tracker for deferred tax purposes, updated every reporting date, independent of the fixed grant date fair value used for the expense.
❌ Treating a repricing as a fresh grant instead of a modification
When exercise terms are amended, some companies wrongly cancel the old award and record a brand new grant at the modified fair value, rather than applying modification accounting, which requires the original fair value to continue being expensed alongside an incremental charge.
Fix: Apply modification accounting whenever the same underlying award continues with amended terms, recognising only the incremental fair value increase as additional expense.
❌ Assuming SEBI SBEB compliance automatically satisfies Ind AS 102
Listed companies sometimes assume that meeting SEBI's scheme design, disclosure and shareholder approval requirements also covers the financial reporting obligation, when the two frameworks address entirely separate concerns.
Fix: Treat SEBI SBEB compliance and Ind AS 102 accounting as parallel workstreams, each requiring its own review, valuation input and sign-off.
Closing Summary: Ind AS 102 Rewards Discipline, Not Shortcuts
Ind AS 102 is a short standard on paper but an exacting one in application, because it demands consistent, tranche level discipline across grant date fair value measurement, graded vesting amortisation, vesting condition classification, and a deferred tax computation that runs on an entirely different measurement base from the accounting expense itself. Companies that build the expense schedule correctly from the grant date, rather than retrofitting it at year end or before an audit, avoid the restatements, qualified opinions and last minute reconciliation exercises that a straight line shortcut or an intrinsic value assumption eventually produces. At Elite Valuation, our ESOP accounting practice combines Ind AS 102 compliant fair value reports, Companies Act grant date valuations, and coordination with SEBI SBEB and income tax perquisite requirements, so that finance teams enter every audit cycle with a defensible, tranche accurate expense trail.
Get an Ind AS 102 Compliant ESOP Valuation and Expense Schedule
Grant date fair value → Graded vesting expense model → Deferred tax computation support → SEBI and Companies Act coordination. One engagement, built to withstand statutory audit and listing scrutiny.
Frequently Asked Questions — Ind AS 102 ESOP Accounting
CA Sagar Shah, Founder
Mr Sagar Shah is the Founder of Elite Valuation and leads the firm’s Valuation and Advisory practice. With over 15+ years of professional experience.
Planning ESOP Pool Refreshes Across Multiple Funding Rounds?
We provide continuity across grant tranches so every valuation uses consistent, defensible assumptions, from your first ESOP pool through to a SEBI-compliant listed company structure.
Published Insights
